Go to Page # Page of 22

Recast Medical Device directives Impacts on materiovigilance

 Journee Vigilance
Description: Stricter pre-market control of high-risk devices with the involvement of a pool of experts at EU level. The inclusion of certain aesthetic devices within the scope. Reinforced designation and oversight processes of notified bodies. Reinforcement of the rules on clinical evaluation (and performance evaluation) and clinical investigation (and performance studies) Stricter rules for "substance-based" devices. New classification system for IVDs based on international guidance (80% of IVDs to be assessed by a Notified Body) Stricter requirements related to the use of hazardous substances for certain devices Introduction of a UDI system.
Views: 1112
Domain: Medical
Category: Equipment
Contributing Organization: FAMHP
 ‐ More of their Presentations
Recast Medical Device directives
Impacts on materiovigilance
Journée Vigilance


Valérie Nys

Revision of the EU Medical Devices Legislation

• Directive 90/385/EEC on active implantable medical
• Directive 93/42/EEC on medical devices

Regulation on medical devices
• Directive 98/79/EC on in vitro diagnostic medical
Regulation on in vitro d ... See more

Recent Presentations

Oncolytic Immunotherapeutics Leadership

The presentation and the accompanying oral commentary contain forward-looking statements within the meaning of the relevant securities laws of the Republic of Korea and the United

SillaJen Inc
18 March, 2018

Basket and Umbrella Trial Designs in Oncology

Historically, phase I conducted with mixture of solid tumors, then phase II and III oncology trials were histopathologic focused (e.g. lung cancer study, breast cancer study, etc.)

Eric Polley
17 March, 2018

Multidisciplinary Approachs in Cancer

The oncology framework is increasingly complex, entailing multiple interactions of all stakeholders involved: patients, European and national policy makers, European and internatio

16 March, 2018